Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Antibe Therapeutics Inc. ATBPF

Set alert

Price alert · ATBPF

All alert types
0.22 +0.22 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
11.43M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—
Earnings
Jul 4, 2024

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ATBPF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-3.77 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.6×
FY 2014: -5.2×FY 2015: -0.6×FY 2016: -3.3×FY 2017: -0.0×FY 2018: -9.2×FY 2019: -5.0×FY 2020: -8.2×FY 2021: -7.3×FY 2022: -1.6×FY 2023: -1.6×
FY 2014 5y median -5.0× FY 2023
P/S 0.0×
FY 2014: 0.0×FY 2015: 141×FY 2016: 2.0×FY 2017: 0.0×FY 2018: 8.0×FY 2019: 6.8×FY 2020: 16.5×FY 2021: 19.5×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 6.8× FY 2023
P/B 0.8×
FY 2014: 4.2×FY 2015: 8.3×FY 2016: 1.9×FY 2017: 0.1×FY 2018: 8.6×FY 2019: 8.7×FY 2020: 42.1×FY 2021: 3.8×FY 2022: 0.7×FY 2023: 0.8×
FY 2014 5y median 3.8× FY 2023
P/FCF -1.9×
FY 2014: -4.7×FY 2015: -0.7×FY 2016: -2.9×FY 2017: -0.1×FY 2018: -10.5×FY 2019: -9.0×FY 2020: -13.3×FY 2021: -1805×FY 2022: -2.4×FY 2023: -1.9×
FY 2014 5y median -9.0× FY 2023
EV/EBITDA -1.3×
FY 2014: -3.8×FY 2015: 122×FY 2016: -4.0×FY 2017: -0.5×FY 2018: -10.8×FY 2019: -5.1×FY 2020: -8.6×FY 2021: -5.1×FY 2022: -0.2×FY 2023: -1.3×
FY 2014 5y median -5.1× FY 2023
EV/Sales 0.0×
FY 2014: 0.0×FY 2015: 121×FY 2016: 2.7×FY 2017: 0.3×FY 2018: 7.8×FY 2019: 6.4×FY 2020: 16.1×FY 2021: 12.1×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 6.4× FY 2023
FCF Yield -52.6%
FY 2014: -21.3%FY 2015: -135.1%FY 2016: -35.0%FY 2017: -1907.7%FY 2018: -9.5%FY 2019: -11.1%FY 2020: -7.5%FY 2021: -0.1%FY 2022: -42.0%FY 2023: -52.6%
FY 2014 5y median -11.1% FY 2023

Profitability

Gross Margin 0.0%
FY 2014: 0.0%FY 2015: -651.4%FY 2016: 46.3%FY 2017: 43.5%FY 2018: 39.7%FY 2019: 37.2%FY 2020: 38.2%FY 2021: 36.5%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 36.5% FY 2023
Operating Margin 0.0%
FY 2014: 0.0%FY 2015: -22152.6%FY 2016: -71.0%FY 2017: -57.5%FY 2018: -78.3%FY 2019: -127.8%FY 2020: -192.6%FY 2021: -242.3%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median -127.8% FY 2023
Net Margin 0.0%
FY 2014: 0.0%FY 2015: -22052.4%FY 2016: -75.8%FY 2017: -63.5%FY 2018: -87.3%FY 2019: -134.4%FY 2020: -200.1%FY 2021: -270.8%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median -134.4% FY 2023
ROE -48.5%
FY 2014: -80.8%FY 2015: -1305.2%FY 2016: -71.5%FY 2017: -161.7%FY 2018: -93.2%FY 2019: -172.2%FY 2020: -511.9%FY 2021: -52.3%FY 2022: -44.1%FY 2023: -48.5%
FY 2014 5y median -52.3% FY 2023
ROIC -30.3%
FY 2014: -80.5%FY 2015: -1311.1%FY 2016: -36.2%FY 2017: -56.1%FY 2018: -60.6%FY 2019: -102.3%FY 2020: -217.0%FY 2021: -30.1%FY 2022: -30.0%FY 2023: -30.3%
FY 2014 5y median -30.3% FY 2023
ROA -27.6%
FY 2014: -61.6%FY 2015: -557.6%FY 2016: -34.5%FY 2017: -53.6%FY 2018: -59.5%FY 2019: -86.5%FY 2020: -139.8%FY 2021: -32.2%FY 2022: -28.1%FY 2023: -27.6%
FY 2014 5y median -32.2% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 22132.8%FY 2017: 104.1%FY 2018: -6.0%FY 2019: 12.1%FY 2020: 1.3%FY 2021: 0.5%FY 2022: -100.0%FY 2023: 0.0%
FY 2014 FY 2023
Operating Income 19.5%
FY 2014: -155.6%FY 2015: -65.5%FY 2016: 28.8%FY 2017: -65.4%FY 2018: -27.9%FY 2019: -82.9%FY 2020: -52.8%FY 2021: -26.4%FY 2022: -8.5%FY 2023: 19.5%
FY 2014 FY 2023
EPS (diluted) 24.5%
FY 2014: -155.0%FY 2015: -16.7%FY 2016: 64.7%FY 2017: -42.9%FY 2018: 18.3%FY 2019: -22.4%FY 2020: -18.3%FY 2021: 1.4%FY 2022: 30.0%FY 2023: 24.5%
FY 2014 FY 2023
Free Cash Flow 3.6%
FY 2014: -509.1%FY 2015: -29.5%FY 2016: 19.4%FY 2017: -20.9%FY 2018: -75.8%FY 2019: -10.9%FY 2020: -65.5%FY 2021: 99.1%FY 2022: -16022.9%FY 2023: 3.6%
FY 2014 FY 2023

Financial Health

Current Ratio 15.0×
FY 2014: 4.2×FY 2015: 1.6×FY 2016: 1.7×FY 2017: 2.0×FY 2018: 2.4×FY 2019: 3.6×FY 2020: 1.5×FY 2021: 21.1×FY 2022: 13.1×FY 2023: 15.0×
FY 2014 5y median 13.1× FY 2023
Quick Ratio 15.0×
FY 2014: 4.7×FY 2015: 1.6×FY 2016: 0.9×FY 2017: 1.1×FY 2018: 1.5×FY 2019: 2.7×FY 2020: 1.1×FY 2021: 20.6×FY 2022: 13.1×FY 2023: 15.0×
FY 2014 5y median 13.1× FY 2023
Debt / Equity 0.0×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.8×FY 2017: 1.1×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.6×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2014 5y median 0.0× FY 2023
Net Debt / EBITDA 0.4×
FY 2014: 1.4×FY 2015: -20.1×FY 2016: -1.1×FY 2017: -0.5×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 3.1×FY 2022: 1.4×FY 2023: 0.4×
FY 2014 5y median 0.4× FY 2023
Interest Coverage -2568×
FY 2014: -176×FY 2015: -11513×FY 2016: -9.1×FY 2017: -6.2×FY 2018: -5.7×FY 2019: -28.3×FY 2020: -37.2×FY 2021: -3697×FY 2022: -3191×FY 2023: -2568×
FY 2014 5y median -2568× FY 2023

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-03-31